|
SLC30A7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.835800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.091200E-01 |
| Normal-vs-Stage2 |
2.411800E-02 |
| Normal-vs-Stage3 |
4.035400E-01 |
| Normal-vs-Stage4 |
3.065800E-01 |
| Stage1-vs-Stage2 |
4.875600E-02 |
| Stage1-vs-Stage3 |
7.118000E-01 |
| Stage1-vs-Stage4 |
5.444000E-01 |
| Stage2-vs-Stage3 |
1.426600E-01 |
| Stage2-vs-Stage4 |
2.538400E-01 |
| Stage3-vs-Stage4 |
7.837000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.556200E-01 |
| Normal-vs-AfricanAmerican |
9.765200E-01 |
| Normal-vs-Asian |
5.878800E-01 |
| Caucasian-vs-AfricanAmerican |
6.058400E-01 |
| Caucasian-vs-Asian |
8.951400E-01 |
| AfricanAmerican-vs-Asian |
7.061600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.690800E-01 |
| Normal-vs-Female |
3.583400E-01 |
| Male-vs-Female |
5.843800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.442200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.118770E-01 |
| Normal-vs-Age(61-80Yrs) |
1.586610E-01 |
| Normal-vs-Age(81-100Yrs) |
8.880800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.157700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.246180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.867200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.206000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.020600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.679800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.277400E-01 |
| Classical-VS-Follicular |
6.21450000000134E-05 |
| Classical-VS-Other |
1.171380E-01 |
| Classical-VS-Normal |
9.979000E-01 |
| Tall-VS-Follicular |
9.776400E-04 |
| Tall-VS-Other |
5.887800E-02 |
| Tall-VS-Normal |
2.923400E-01 |
| Follicular-VS-Other |
8.261200E-01 |
| Follicular-VS-Normal |
4.079700E-03 |
| Other-VS-Normal |
8.713900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.604000E-02 |
| Normal-vs-N1 |
4.408800E-01 |
| N0-vs-N1 |
3.727800E-01 |
|
|
